World Health Organization confirms the susceptibility of seasonal AH1N1 to

10/11/2009

WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza Viruses published on August 20th, 2009 confirms that seasonal AH1N1 is susceptible to Remantadine (INN: rimantadine) and Neomidantane (INN: admantadine).


 

“It is indeed an outstanding achievement of Latvian pharmaceutical company when active ingredients of Remantadine and Neomidantane are confirmed to be effective in treatment of seasonal AH1N1 by the WHO. Our scientists had been able to develop formulae with which only two other in a whole world are able to compete,” Mrs. Liga Gibnere, Deputy Development Director of Olainfarm says. “Assessment of susceptibility to antiviral medicines is made difficult by very rapid transformations of A type viruses over one or more years. Therefore, even if the medicine has not been effective in treatment of one form of influenza virus, it does not necessarily mean that it will not be effective in other cases. WHO, which is internationally best reputed opinion leader and monitor in health care admits that rimantadine and amantadine, produced also by Olainfarm are effective in treatment of seasonal AH1N1 influenza. Importance of so called swine flu should not, however, be overestimated, as our recent experience shows that seasonal flu influences by far greater number of people, especially elderly ones,” says Mrs. Gibnere.

 

Remantadine is the only OTC antiviral medicine, it is safe and time-tested, stocks of that product in Latvia are sufficient.

 

Let us remind you, that in order to avoid contracting, it is necessary to constantly maintain the healthy lifestyle, through taking balanced nutrition, full in natural vitamins, reducing the impact of stress on your body and carefully observing the personal hygiene.

 

Remantadine or its active ingredient produced by Olainfarm AS “Olainfarm” has been sold to Norway, Poland, Bulgaria, USA, CIS countries. In total the product is being exported to nearly 20 countries.

 

WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza Viruses) : //www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf

 

JSC Olainfarm is one of the biggest companies in the Baltic States with more than 35 years of experience in production of medicines and chemical and pharmaceutical products. The basic principle of Company#ins_quot2#s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Currently the products of JSC Olainfarm are being exported to more than 30 countries worldwide, including the Baltics, Russia, CIS, Scandinavian and other Western European countries, Asia and the USA.

 

Information prepared by
Salvis Lapins
JSC “Olainfarm”
Deputy CFO
tel. +371 6 7013717,
cell: + 371 2 6448873
fax. + 371 6 7013777
slapinsh@olainfarm.lv